In recent years, consumers have expressed greater interest in the nutritional content of the foods they eat. However, there is a great deal of confusion by both consumers and manufacturers on what exactly makes for a “healthy” product. To address this confusion, and account for recent nutrition research, FDA will soon release its revised guidance on using the word healthy on food product labels, essentially redefining the term. Panelists will address the most pressing issues the guidance is likely to or should address, as well as how the guidance may impact pending and future health claim-focused litigation.
Robert Earl, Director, Regulatory Policy and Intelligence, Kerry, Inc.
Marisol C. Mork, Partner, Squire Patton Boggs LLP
Sarah Sorscher, Deputy Director of Public Affairs, Center for Science in the Public Interest (CSPI)
Moderated by Sarah Roller, Partner, Kelley Drye & Warren LLP